Alternatives to naltrexone in animal models.
Overstreet
D H
DH
Skipper Bowles Center for Alcohol Studies, University of North Carolina, Chapel Hill, USA.
D000077443:Acamprosate; D000427:Alcohol Deterrents / Q000009:adverse effects / Q000627:therapeutic use*; D000437:Alcoholism / Q000534:rehabilitation*; D000818:Animals; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical; D000882:Haplorhini; D006801:Humans; D009271:Naltrexone / Q000009:adverse effects / Q000627:therapeutic use*; D009292:Narcotic Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D051381:Rats; D012702:Serotonin Antagonists / Q000627:therapeutic use; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use; D013654:Taurine / Q000031:analogs & derivatives / Q000627:therapeutic use; D013973:Thyrotropin-Releasing Hormone / Q000031:analogs & derivatives / Q000627:therapeutic use
D000427:Alcohol Deterrents; D009292:Narcotic Antagonists; D012702:Serotonin Antagonists; D017366:Serotonin Receptor Agonists; C065049:TA 0910; D013654:Taurine; D009271:Naltrexone; D013973:Thyrotropin-Releasing Hormone; D000077443:Acamprosate